CG
BHVN

Caprock Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Caprock Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,546
Closed -$420K – 655
2022
Q1 		$420K Buy
3,546
+1,066
+43% +$126K 0.04% 334
2021
Q4 		$342K Buy
2,480
+299
+14% +$41.2K 0.03% 381
2021
Q3 		$303K Buy
+2,181
New +$303K 0.03% 373